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Genotypes
>0.05 C 81 9, 11.11 B/C mixed 3 0, 0.0 respectively (p > 0.05); 70% of patients with natural YMDD motif were male compared to 68.7% of patients without natural YMDD motif (p > 0.05). Some previous studies showed that natural YMDD motif mutation was not associated with age and gender of patients, 3-5 which is consistent with the results of this study. In present study, the prevalence rate of natural YMDD mutations among HBeAg positive and HBeAg negative patients were not significantly different (p > 0.05) (Table 1) . This finding is contrast with some previous reports, 3,4 but in line with other reports. 2 The relationship between the HBV genotype and natural YMDD mutations is not clearly identified. Some previous researchers reported that most natural YMDD motif mutations occurred in patients infected with genotype C and its mixed forms. 2, 4 In contrast, our results showed no association between natural YMDD motif mutations and HBV genotype (p > 0.05) (Table 1 ).
In addition, the prevalence rate of YMDD in patients with high HBV-DNA level (≥10 5 copies/mL) was higher than those with low HBV-DNA level (<10 5 copies/mL), but the difference was not significantly different (p > 0.05) (Table 1 ). This result is not consistent with previous studies, which suggested an association between higher HBV-DNA level and increased prevalence of natural YMDD mutations. 4,5 Whether the b r a z j i n f e c t d i s . 2 0 1 6;2 0(6):645-646 HBV-DNA level is indeed associated with higher prevalence of YMDD mutations warrants more studies.
This study shows that the natural YMDD motif mutations do exist in a proportion of treatment-naive CHB patients in eastern China. These findings suggest that it is necessary to screen for YMDD resistance mutations before LAM therapy. Further large-scale, multi-center and follow-up studies are needed to elucidate the mechanism and clinical significance of natural YMDD motif mutations in HBV chronically infected patients.
